News from NYU Langone Health
Most People Delay This Cancer Screening—but It Should Be Your #1
Parade Magazine
A 2025 survey by the Prevent Cancer Foundation found that only 51% of U.S. adults had a routine cancer screening in the past year, a 10% drop from 2024. The article highlights the rising rates of colorectal cancer, particularly among people younger than 55, and reinforces the recommendation to begin screenings at age 45. Experts note that colonoscopies can detect and prevent cancer by removing precancerous polyps. Paul E. Oberstein, MD, associate professor in the Department of Medicine and director of the Gastrointestinal Medical Oncology Program at NYU Langone’s Perlmutter Cancer Center, explains that screenings are typically covered by insurance for this age group.
Also reporting was: Fort Worth Star-Telegram, The Modesto Bee, Miami Herald, Lexington Herald-Leader, Yahoo, Aol, The Sun News, Fresno Bee, Wichita Eagle
1/08/2026
26 healthcare marketing priorities at 17 top health systems
Becker's Hospital Review
Becker’s reached out to chief marketing officers at some of the nation’s biggest health systems to find out their top priorities for the next 12 months. Elizabeth Golden, Executive Vice President of Communications, Marketing, Government and Community Affairs at NYU Langone Health, said: “As a health system focused on enhancing patient experience and improving access, we must meet people where they are on their healthcare journey. A targeted, omnichannel approach enables us to guide patients and caregivers to the right care at the right time…Our communications also need to be clear and relevant, empowering decision-makers to evaluate their options based on access, reputation and the experience they want as patients.”
1/08/2026
Amy Poehler's podcast is a hit. It's also a Trojan horse for talking about women and aging.
Yahoo Entertainment
An article highlights Amy Poehler's podcast, 'Good Hang,' for normalizing conversations about women's aging and menopause. Julia Adamian, MD, an internist at NYU Langone Health, and medical director, NYU Langone Internal Medical Associates, notes that discussing these topics outside of a medical setting reduces stigma, framing menopause as a natural life stage rather than a disease. Samantha M. Dunham, MD, co-director of NYU Langone Health’s Center for Midlife Health and Menopause, adds that Poehler's humorous and candid approach is refreshing and helps women feel they are not alone in navigating the experience.
1/08/2026
Tukysa Makes Waves as Firstline Maintenance in HER2+ Breast Cancer
CURE Magazine
In an interview with CURE, Joshua K. Sabari, MD, assistant professor in the Department of Medicine at NYU Grossman School of Medicine and director of High Reliability Organization Initiatives at NYU Langone’s Perlmutter Cancer Center, spoke with Erika Hamilton, MD, of the Sarah Cannon Research Institute. They discussed the HER2CLIMB05 clinical trial, which evaluated Tukysa as a first-line maintenance therapy for HER2-positive metastatic breast cancer. The trial found that adding Tukysa improved progression-free survival by nearly nine months. Side effects included manageable diarrhea and elevated liver enzymes. The drug also showed a positive signal for patients with brain metastases.
1/08/2026
Is Inflammation the Key to Women’s Heart Health?
Medscape
A study in The European Heart Journal suggests high-sensitivity C-reactive protein (hsCRP) is a key predictor of cardiovascular disease in women without standard modifiable risk factors. The research found women with elevated hsCRP had a significantly increased risk for coronary heart disease and stroke. Nieca Goldberg, MD, clinical associate professor of medicine in the Leon H. Charney Division of Cardiology at NYU Grossman School of Medicine, commented that it is important to look for factors like inflammation when patients have heart attacks without traditional risk factors. The article also includes commentary from experts at Northwell Health and Johns Hopkins.
1/07/2026
Your Health Tracker Knows You Didn’t Sleep Well. Does That Help—or Hurt?
Bloomberg News
The use of wearable health-tracking devices is increasing, offering users detailed metrics on sleep, activity, and heart rate. While some find the data motivational, doctors worry that data overload and hyperfixation can cause stress and anxiety. Thea Gallagher, PsyD, clinical associate professor and director of Wellness Programs in the Department of Psychiatry at NYU Langone Health, notes that this technology needs monitoring so it does not take over people's lives. She has observed patients obsessing over metrics like heart-rate variability and compares the devices to a scale, which can be unhealthy for some individuals, creating a 'doom loop' of worry.
1/09/2026
Florida Trend
Julian Mackay-Wiggan, MD, clinical professor, Department of Dermatology, Julia Koch Family Ambulatory Care Center—West Palm Beach, addressed several topics related to skin health. She noted that while sun awareness has increased, skin cancer rates have not decreased, partly because people using sunscreen may stay in the sun longer without reapplying properly. Dr. Mackay-Wiggan debunked sunscreen myths, recommended mineral-based sunscreens, and stated that annual physicals are not sufficient for skin cancer screenings. She also explained that even one tanning bed session statistically increases melanoma risk.
1/08/2026
Designing for Health, Designing with Care
Metropolis Magazine
At the METROPOLIS 2025 Synergy conference, leaders from Memorial Sloan Kettering, Mayo Clinic, and NYU Langone Health discussed how sustainability is foundational to healthcare architecture. Victoria Kocian, project manager for energy and sustainability, real estate development and facilities, NYU Langone Health, detailed the system's commitment to carbon neutrality by 2050 and a 50 percent emissions reduction by 2030. She highlighted that NYU Langone Health published its first public sustainability report in 2023 and is opening an all-electric Brooklyn Ambulatory Hub in early 2026. The panel also included leaders from Memorial Sloan Kettering and Mayo Clinic.
1/08/2026
Hospitals postpone elective surgeries as flu strains capacity
Becker's Hospital Review
Hospitals nationwide are delaying elective procedures to manage capacity amid a severe flu season that is filling emergency departments. New York state reported a record 4,546 flu hospitalizations in a single week. Michael Phillips, MD, director of the division of Infectious diseases at NYU Grossman School of Medicine and chief epidemiologist at NYU Langone Health, commented on the situation, noting that the season has been severe with a rapid onset. He added that New York was hit hard and early, and that emergency departments are packed.
1/08/2026
NYC Health Department Flu Update
FOX 5 THE 5 O'CLOCK NEWS
Purvi S. Parikh, MD, immunologist and clinical assistant professor in the Department of Medicine at NYU Grossman School of Medicine, discusses New York City's flu season, noting that while cases are declining, the city has seen the highest number of cases since 2004. She emphasizes that it is not too late to get vaccinated, as the flu season can last until May. Dr. Parikh also comments on the Trump administration's new dietary guidelines, which invert the food pyramid. She points out that while it still promotes vegetables and protein, its new emphasis on fats like beef tallow and full-fat dairy is a departure from previous advice and could have negative cardiovascular consequences.
1/08/2026
What doctors want you to know before you take a prescription drug off-label
National Geographic
The article examines the increasing trend of people using prescription drugs off-label for longevity and wellness, driven by a 'fast medicine' culture. Art Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics in the Department of Population Health at NYU Grossman School of Medicine, attributes this to a desire for a 'magic bullet' over healthy habits. He notes that direct-to-consumer marketing and a U.S. business model allowing off-label prescribing fuel this trend. Caplan also warns that widespread off-label use can hinder scientific progress by preventing proper clinical studies of these drugs.
1/08/2026
Science Magazine
The Trump administration, via the CDC, is reducing the number of recommended childhood vaccines, citing a need for more placebo-controlled trials for vaccines against diseases like hepatitis A and meningococcal disease. Many scientists disagree, arguing the current vaccines are safe and effective and that new placebo-controlled trials would be unethical. The article cites Arthur Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics at NYU Grossman School of Medicine, who co-authored a paper explaining that control groups must receive the highest standard of care and not be denied effective treatments.
1/08/2026
